Assess the reporting quality of randomized controlled trials exploring the efficacy and safety of the new anticoagulants versus warfarin in patients with atrial fibrillation, based on CONSORT statement

dc.contributor.advisor	Ζιντζαράς, Ηλίας	el
dc.creator	Καράκου, Ευγενία Δ.	el
dc.date.accessioned	2017-04-26T09:09:48Z
dc.date.available	2017-04-26T09:09:48Z
dc.date.issued	2015
dc.identifier.other	14310
dc.identifier.uri	http://hdl.handle.net/11615/46166
dc.identifier.uri	http://dx.doi.org/10.26253/heal.uth.4012
dc.language.iso	en	en
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International	en
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	en
dc.subject.other	Καρδιαγγειακή φαρμακολογία	el
dc.subject.other	Κολπική μαρμαρυγή	el
dc.subject.other	Αντιπηκτικά	el
dc.title	Assess the reporting quality of randomized controlled trials exploring the efficacy and safety of the new anticoagulants versus warfarin in patients with atrial fibrillation, based on CONSORT statement	en
dc.type	masterThesis	en
heal.recordProvider	Πανεπιστήμιο Θεσσαλίας - Βιβλιοθήκη και Κέντρο Πληροφόρησης	el
heal.academicPublisher	Πανεπιστήμιο Θεσσαλίας. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής.	el
heal.academicPublisherID	uth	en
heal.fullTextAvailability	true	en
dc.rights.accessRights	free	en

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International